Overview

Advancing Tobacco Use Treatment for African American Smokers

Status:
Completed
Trial end date:
2018-07-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether or not providing Chantix (varenicline) will help African American smokers quit smoking.
Phase:
Phase 4
Details
Lead Sponsor:
Lisa Sanderson Cox, PhD
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Varenicline